This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The second quarter of 2025 saw some huge successes and fails in the psychiatric treatment pipeline. What percentage of 2025 Q2 psychiatric pipeline news was positive vs negative? Together, they will aim to bring innovative mentalhealth treatments to patients in need. Learn more in this exclusive article.
Do you have practice tips to offer your fellow mentalhealth clinicians? Accessed August 1, 2025. children, highlighting its significant prevalence and rising diagnosis rates. children, highlighting its significant prevalence and rising diagnosis rates. What comorbidities do you often see with ADHD in your practice?
Emerging research on RNA biomarkers, AI applications, and genetic mutations shows promise for developing new diagnostic tools for bipolar disorder. Focusing on patient symptom insight, clinician investigation, and new tests with potential to measure this disorder may provide better care for patients suffering from bipolar disorder.
J ust about everyone believes that depressionthe #1 psychiatric diagnosisis explained in the same way as physical illnesses; that is, that depression, too, is of genetic/physiological origin. NIMH and psychiatrists have not always explained depression to be genetic (as “running in the family). Their efforts have failed.
SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Health care professionals should monitor the child’s growth and development and provide necessary interventions to mitigate weight loss.”
PTSD diagnosis requires nuanced understanding, as symptoms often overlap with other psychiatric disorders, complicating discernment. Genetic links between PTSD and migraines suggest shared pathways, with genes DAPK2 and TM6SF2 implicated in both disorders.
Related Videos Related Content Advertisement June 17th 2025 ADHD With Bipolar Disorder: Genetics, Diagnosis, and New Thinking on Treatment David N. Subscribe Now!
Overview of Attention Deficit/Hyperactivity Disorder EP: 2. Role of Pediatricians in Diagnosing ADHD ADHD risk factors encompass both genetic and environmental components that significantly impact child development. Risk Factors for ADHD EP: 7. Subscribe Now!
Both medications carry important safety considerations including potential for increased suicidal ideation, requiring careful monitoring and education about distinguishing medication-related intrusive thoughts from situational mentalhealth concerns. Subscribe Now!
NRx is targeting suicidal depression and PTSD with NRX-100, anticipating an FDA decision by the end of 2025. The company continues to anticipate an FDA decision on NRX-100 by the end of 2025. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.
Studies in Australia and the United States followed individuals with subthreshold psychotic symptoms and functional decline, along with a genetic risk for schizophrenia, over time. Research indicates that only 20% to 40% of individuals who meet ultra–high risk (UHR) criteria convert to psychosis within 2 to 4 years.
Before reaching specialized behavioral health services, families typically consult pediatricians who must possess comprehensive knowledge of ADHD presentation, diagnostic criteria, and evidence-based treatment approaches. Subscribe Now!
A Brief Group Social-Belonging Intervention to Improve Mental-Health and Academic Outcomes in BIPOC and First-Generation-to-College Students Erin S. Understanding Ethnoracial Disparities and Advancing MentalHealth Equity Through Clinical Psychological Science: Introduction to Special Issue P. Pritchard, Jennifer L.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content